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Correlation of bone histology with parathyroid hormone, vitamin D3,
and radiology in end-stage renal disease. We analyzed transiliac bone
biopsy specimens from 30 end-stage renal failure patients, taken at the
time of admission for CAPD training. Results were compared with
values of iPTH, bone alkaline phosphatase, I ,25-dihydroxyvitamin D3,
skeletal survey, quantitative computed tomography (QCT) and single
photon absorptiometry (SPA) bone density measurements. Osteitis
fibrosa was the most common histological diagnosis, present in 15 of the
30 patients (50%), with eight classified as "severe" and seven as
"mild." Eight patients (27%) had adynamic bone lesion, four mixed
renal osteodystrophy (13%), and two (7%) osteomalacia. The mean age
of the adynamic group was higher than the osteitis fibrosa group (41
12.1 vs. 56 10.2 years; P <0.01), and than the mixed group (39 7.5
vs. 56 10.2 years; P < 0.02). Levels of iPTH enabled discrimination
between groups, but not between individual patients, and values
correlated with bone alkaline phosphatase (r = 0.62; P < 0.001).
Erosion of the terminal phalanges was seen on the plain X-rays of 7 of
15 patients with mild or severe OF, and in three patients with another
diagnosis. The majority of patients (>90%) had bone density measure-
ments within the normal range. No significant correlation existed
between QCT or SPA scores and any of the histomorphometric
parameters, or iPTH. We conclude that iP'l'H is the most helpful
non-invasive investigation in this group of patients. Plain X-ray of the
hands is the most useful radiological investigation, but single measure-
ments of bone density are not diagnostic.
Abnormalities of mineral metabolism and bone impart signif-
icant morbidity and mortality to patients with end-stage renal
disease [1]. Renal bone disease has its origins early in the
course of renal failure [2, 31, so that by the time GFR has fallen
to 50% of normal, at least 50% of the patients exhibit abnormal
bone histology [1, 4]. In a study of 16 patients with creatinine
clearances between 20 and 59 ml/min, Baker et a! found all of
them to have abnormal bone histology [5]. Since few of these
patients are symptomatic, diagnosis of bone disease has de-
pended on routine examination of various biochemical param-
eters, and skeletal radiology. Generally available techniques
include measurement of serum 25-hydroxy-, and 1 ,25-dihy-
droxy-vitamin D3, serum parathyroid hormone fragments, total
serum alkaline phosphatase, serum aluminum levels (some-
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times in conjuction with a desfemoxamine mesylate infusion
test), and plain skeletal X-rays (the so-called "skeletal sur-
vey"). However, as pointed out by Malluche and Faugere,
serum biochemical parameters are relatively poor predictors of
the type and severity of bone disease, while information ob-
tained from skeletal X-rays is limited and often misleading. In
addition most radiologic signs considered to be pathognomonic
of severe osteitis fibrosa can be found in any of the three
histological types of renal osteodystrophy [1].
In recent years, other techniques have been developed for
examining bone disease including measurement of the intact
parathyroid hormone molecule by radioimmunoassay [6], se-
rum bone alkaline phosphatase, and measurement of bone
density and mineral content by single or dual photon densitom-
etry, plus quantitative CT scan [7, 8]. We used these non-
invasive techniques to measure the above parameters in a group
of patients with end-stage renal disease, prior to the start of
dialysis, and compared them with bone histomorphometry,
accepted as the 'gold standard' for assessing renal osteodystro-
phy.
Since hyperparathyroidism, osteomalacia and the adynamic
bone lesion might all be expected to lead to a low bone mass,
our hypothesis was that patients with these diagnoses may be
readily identifiable by measurements of bone density, and that
biochemical markers could then allow differentiation between
the groups. Therefore, the aim of our study was to determine
the presence and type of renal osteodystrophy by bone biopsy,
and to correlate the histomorphometric findings with a variety
of non-invasive techniques.
Methods
Patients
Thirty patients in end-stage renal failure (creatinine clearance
5 mllmin) were enrolled in the study (7 females, 23 males).
Their mean age was 47 (range 25 to 71) years, and the etiology
of their renal failure was chronic glomerulonephritis six, adult
polycystic kidney disease five, hypertension four, chronic py-
elonephritis two, diabetes mellitus three, others three, and
unknown seven. Three of the seven female patients were
post-menopausal (aged 52, 54 and 57 years); however, all seven
had developed amenorrhea during the course of their chronic
renal failure. Patients had not previously received any renal
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replacement therapy, and none had clinical signs or symptoms
of overt bone disease, nor undergone parathyroidectomy. Their
treatment comprised calcium carbonate (2 to 10 g/day) taken
with meals as a phosphate binder, supplements of iron, vitamin
B complex, ascorbic acid, and antihypertensive drugs. None
was taking aluminum-containing phosphate binders at the time
of starting dialysis, but five had previously taken them for
variable periods during the course of their renal failure.
Bone biopsy and radiological examinations were performed
during the time of admission to the hospital for commencement
of dialysis. With the exceptions of serum iPTH and aluminum,
quoted results represent means of two samples taken in the
month before admission. Serum IPTH and aluminum results are
from single assays of blood taken immediately prior to begin-
ning peritoneal dialysis.
The study was approved by the Central Manchester Health
Authority Ethical Committee.
Biochemistry
Ionized calcium was determined using a Radiometer ICA2
electrode. An American Monitor parallel analyzer was used to
measure serum levels of phosphate (polyvinylpyrrolidone cat-
alysed phosphate-molybdate reaction). Serum concentration of
immunoreactive intact-molecule parathyroid hormone was
measured by immunoradiometric whole molecule "sandwich"
assay (Nichols Allegro). Aluminum levels were determined by
electro-thermal atomic-absorption spectrometry (Perkin-Elmer
Zeeman 3030 with an HGA-600 furnace). The bone isoenzyme
of alkaline phosphatase, 25-hydroxy and 1 ,25-dihydroxyvitamin
D3 were measured by methods already described [9—11].
Radiology
Each patient underwent: (1) skeletal survey comprising plain
radiographs of hands, chest/clavicles, lateral lumbar and tho-
racic spine, and pelvis. All radiographs were taken by the same
radiographer.
(2) Measurement of vertebral trabecular bone mineral density
was performed by quantitative computed tomography (QCT) on
a General Electric 9800 general purpose scanner, using both
single-energy and dual-energy low dose scanning techniques
[12]. Single 10 mm thick sections were performed through the
middle of the vertebral bodies T12 to L3 at 80 kVp, 70 mA, 2
second scan time for the single energy technique and were
repeated at the same sites using 140 kVp, 10 mA, 2 second scan
time to combine with the 80 kVp scans for the dual-energy
technique. An oval region of interest was selected in the
trabecular bone of the vertebra, excluding the cortex and the
area of entry of the basi-vertebral vein. The attenuation of this
region of interest was compared with a regression line of
attenuation versus concentration of dipotassium hydrogen
phosphate, measured from a phantom scanned with the patient.
Mineral content was measured in mg/ml of mineral equivalents
of K2HPO4 in water. Precision of the single-energy QCT
measurement in a general patient population within the Depart-
ment had previously been measured at 1% (same operator) to
2.5% (different operators) [13]. Dual-energy QCT had a poorer
precision than the single-energy technique but was used to
correct for the negative effect of marrow fat on the estimation of
mineral density by single-energy QCT [7].
(3) Bone mineral estimation in a peripheral skeletal site was
performed by single photon absorptiometry (SPA) in the non-
dominant forearm using a Nuclear Data scanner with an 1125
radionuclide source [14]. The forearm was placed into a water
bath and preliminary rectilinear scanning determined the posi-
tion of the 8 mm gap between the medial cortices of the distal
radius and ulna, When this site was identified, six rectilinear
scans were performed distally and six proximally to obtain bone
mineral density in these two sites. The bone mineral measure-
ment in the proximal site was principally cortical bone and that
in the distal site was integral (cortical + trabecular) bone, but
predominantly trabecular. The precision of the SPA measure-
ment in a general patient population within the department had
been previously measured at 1% for the proximal cortical site
and 2.8% for the distal integral site.
All radiological investigations were reported by one radiolo-
gist (JEA) without prior knowledge of biochemical or histolog-
ical results.
Bone histomorphometry
Each patient received a double label with one gram of oral
tetracycline on day 1 and day 10. Transiiac bone biopsy was
performed two days after the last tetracycline dose. Eight
millimeter bone trephines were split longitudinally using a fine
jeweler's saw. Each half was embedded in methyl methacry-
late. Seven micrometer serial sections were taken from the cut
face of each block and three sets of ten step serial sections
taken at 50 pm intervals were stained with von Kossa's stain,
toluidine blue and solachrome azurine. In addition 20 pm
unstained sections were cut for examination of tetracycline
fluorescence in ultraviolet light.
The sections were analyzed histomorphometrically using a
VIDS II image analyzer for the following parameters, which are
expressed according to the standardized nomenclature [15]:
(1) Static
trabecular bone volume (TBV%)
osteoid surfaces (OsS%)
relative osteoid volume (ROV%)
mean osteoid thickness (MOT sm)
osteoblastic surfaces (ObS%)
mineralizing surfaces as a proportion of
total trabecular bone surfaces (MS%)
eroded surfaces (ErS%)
osteoclast surfaces (OsS%)
osteoclast numbers (OcN x 102/mm2)
degree of paratrabecular marrow fibrosis (MF)
aluminum staining (AIuS)
(2) Dynamic
trabecular appositional rate (TAR mIday)
bone formation rate (BFR%/year)
The histomorphometry and bone density data are presented
as Z scores in order to relate them to age- and sex-matched
normal values derived from healthy volunteers and persons
who died suddenly due to trauma. For example, a Z score of + 1
or —1 indicates a value + 1 or —1 SD from the normal mean. This
is necessary because of the significant changes in normal ranges
for these histomorphometric parameters that occur with aging.
On the basis of the histomorphometry, the patients were
classified into the following groups: (1) idiopathic adynamic
bone, defined as a decreased BFR with a mineralization defect,
such that BFR and MS fell more than 2 SD below the normal
BY/TV
OS/BY
OV/BV
ObS/BS
MS/BS{dLS
+ '/ssLS}
ESIBS
OcS/BS
OcN/TVt
BFRJBVt{dLS
+ V2SLS}
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Table 1. Comparison of histomorphometric parameters
Histological parameter Adynamic Mild OF Severe OF Mixed ROD
Static
Trabecular bone volume —0.63 0.27 —0.82 0.25 —0.39 0.39 —0.57 0.78
Osteoid surfaces 3.37 1.52 3.46 1.72 3.70 1.62 5.98 2.46
Relative osteoid volume 0,83 1.64 1.12 0.22 2.65 1.78 0.39 1.43
Mean osteoid thickness —2.59 0.62 —1.29 0.69 —0.76 0.25 —0.18 0.43
Osteoblast surfaces —3.07 1.16 5.51 1.92 5.57 2.19 8.50 6.27
Mineralizing surfaces —2.84 0.43 3.34 0.90 3.45 1.45 0.68 1.73
Eroded surfaces 0.78 1.53 3.95 0.65 5.51 0.26 3.65 1.48
Osteoclast surfaces —2.54 0.76 2.13 0.50 5.50 0.38 3.50 1.44
Osteoclast numbers x102 2.68 1.47 33.16 5.14 108.11 23.28 19.70 10.26
Dynamic
Trabecular appositional rate —4.84 0.12 —1.21 1.03 —1.44 1.01 —4.37 0.27
Bone formation rate —3.42 0.28 —1.24 0.73 —1.25 0.62 —360 0.40
mean, plus osteoblastic surfaces, osteoclast numbers and os-
teoid thickness within, or below, the normal range, all in the
absence of aluminum staining; (2) mild osteitis fibrosa, defined
as eroded surfaces increased to between 2 and 3 SD above the
normal mean, plus either increased osteoclast surfaces (>2 SD
above the normal mean), or increased osteoclast numbers (>20
x l02/mm2); (3) severe osteitis fibrosa, defined as eroded
surfaces and osteoclast surfaces both increased by more than 3
SD above the normal mean, plus osteoclast numbers greater
than 40 x 102/mm2 (normal range 0.1 to 20 x 1021mm2); (4)
osteomalacia, defined as the presence of thickened osteoid
seams and increased osteoid volume (> 2 SD above the normal
mean) but with a decreased BFR (>2 SD below the normal
mean); (5) mixed renal osteodystrophy, defined as increased
eroded surfaces and/or osteoclast surfaces (>2 SD above the
normal mean) and/or increased osteoclast numbers (>20 X
102/mm2), coexisting with a mineralization defect.
Statistics
Group data are presented as mean (± SEM), unless otherwise
stated. Individual histomorphometric data, QCT and SPA re-
sults are presented as Z scores (numbers of standard deviations
above or below the mean of age- and sex-matched normal
values), with values greater than 10 SD from the mean truncated
to equal 10.
Statistical analysis of differences between groups was per-
formed by analysis of variance using the Fisher PLSD test.
Possible relationships between biochemical and histomorpho-
metric variables were analyzed by linear correlation and calcu-
lation of Kendall's rank correlation coefficient.
The positive predictive value (that is, the proportion of test
positives that are truly positive) of iPTH measurements for the
diagnosis of histological bone disease was expressed in terms of
sensitivity (true positives, as a percentage of true positives plus
false negatives) and specificity (true negatives, as a percentage
of true negatives plus false positives).
Results
Bone histomorphometry
Osteitis fibrosa was the most common histological diagnosis,
being found in 15 of the 30 patients (50%), with eight classified
as "severe" and seven as "mild." Eight patients (27%) were
found to have the adynamic bone lesion and four had mixed
renal osteodystrophy (13%). Only two (7%) had true osteoma-
lacia with greatly increased osteoid thickness and volume, plus
a complete failure of mineralization and depressed BFR. Be-
cause N = 2 in this group, these patients are not compared
statistically with the other groups.
No particular etiology of renal failure appeared to be associ-
ated with any one histological diagnosis, and in particular, none
of the patients in the adynamic group had diabetes mellitus.
However, the mean age of the adynamic group was significantly
higher than the osteitis fibrosa group (41 12.1 vs. 56 10.2
years; P < 0.01), and than the mixed osteodystrophy group (39
7.5 vs. 56 10.2 years; P < 0.02). From a review of case
notes, an attempt was made to assess duration of renal failure
before start of CAPD, but in several cases it was difficult to be
accurate, especially where patients presented in established
end-stage renal failure of unknown etiology. There appeared to
be a tendency for duration to be longer in the adynamic group
(geometric mean 10.9 vs. 7.1 years) but the difference was not
significant. The histomorphometric parameters of the five his-
tological groups are compared in Table 1. Many of the differ-
ences between the adynamic group and the rest are "artificial"
in that they are a result of the selection criteria used for
classification. However, in the adynamic group osteoid thick-
ness and osteoblast surfaces were significantly lower than in the
severe OF group (P < 0.05), while osteoclast surfaces, oste-
oclast numbers, trabecular appositional rate and bone forma-
tion rate were significantly lower than in both the severe and
mild OF groups (P < 0.01). This emphasizes the almost
complete inactivity of all bone cells in the adynamic lesion.
Bone formation rate and trabecular appositional rate were
within the normal range in only ten of the patients, all of whom
had osteitis fibrosa. The other'20 patients all had reduced BFR
and TAR, which was unmeasurably low (no double labeled
surfaces) in 14 cases. Significant aluminum staining was found
in only two patients (numbers 17 and 24).
Biochemistry
The correlations between iPTH levels and individual histo-
morphometric parameters are shown in Table 2. In those
patients showing a double label, a good correlation existed with
BFR and TAR (r = 0.75 and 0.76, respectively; P < 0.01), as
well as the three parameters of bone resorption activity. iPTH
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Histological parameter
Correlation coefficient
iPTH Bone alk phos
Static
Trabecular bone volume 0.04 0.04
Osteoid surfaces 0.20 0.12
Relative osteoid volume 0.38 0.27
Mean osteoid thickness 0.30 0.25
Osteoblast surfaces 0.50 0.43
Mineralizing surfaces 0.58a 0.35
Eroded surfaces 0.49a 0.52
Osteoclast surfaces 0.61" 0.47
Osteoclast numbers 0.63" 0.14
Dynamic
Trabecular appositional rate 0.79a 0.77
Bone formation rate 0.75a 0.76
also correlated with bone alkaline phosphatase (r = 0.62; P <
0.001), but not with total alkaline phosphatase.
For the group as a whole, iPTH was found to correlate
negatively with age (P < 0.04). The mean iPTH value for each
group except Mixed ROD, was significantly different from all
the other groups (Table 3, Fig. 1), with ABD having the lowest
geometric mean (21.6 1.6 pg/mi), and Severe OF having the
highest (495.2 1.2 pglml). Mixed ROD was significantly
different from Severe OF (P < 0.05), but not from Mild OF or
ADB. With the exception of patient 8, all the ADB patients had
iPTH levels within or below the normal range of 10 to 65 pg/mI,
while in contrast the Severe OF group's values ranged from 215
to 900 pg/ml. In total, nine patients had serum iPTH levels
within the normal range and of these, seven had ADB on
biopsy.
Mean serum ionized calcium was also significantly higher in
ADB than in both the mild and severe OF groups (1.27 0.05
vs. 1.09 0.5 and 1.11 0.06 mmol/liter, respectively; P <
0.05; Table 3). ADB had the lowest mean serum phosphate level
at 1.34 0.11 mmol/liter, and this was significantly lower than
Severe OF (2.20 0.25 mmollliter; P < 0.01). There were no
differences between any of the groups' serum aluminum levels,
but bone alkaline phosphatase levels were lower in ADB than in
both Severe OF (36.6 3.6 vs. 68.5 9.2 U/liter; P < 0.01) and
Mild OF (36.6 3.6 vs. 55.3 11.4 U/liter; P = NS), mirroring
the pattern seen with iPTH.
The positive predictive value of iPTH in the diagnosis of
ADB and OF was assessed in all 30 patients. The sensitivity of
an upper limit of iPTH at 65 pg/ml in identifying patients with
ADB was 88%, with a specificity of 91% (Table 4). An iPTH
value greater than 200 pg/ml was helpful in identifying patients
likely to have either mild or severe OF, with a sensitivity of 83%
and specificity of 88%, giving a positive predictive value of
88%. These results could not be improved by taking into
account any specific range of ionized calcium or bone alkaline
phosphatase.
1,25-Dihydroxyvitamin D3 levels were low in all patients
(range 0 to 8 pg/mI; normal = > 20 pg/ml), but were significantly
lower in ABD, than in Severe OF (2.4 0.8 vs. 5.3 0.7 pg/ml;
P < 0.03).
Radiology
The majority of patients' QCT scores lay within 2 SD of the
mean of age- and sex-matched normal values, and there were no
significant differences between any of the groups' mean values
(Fig. 2). However, the group of 30 patients as a whole had a
mean Z score of —0.61, which is significantly reduced compared
to age- and sex-matched controls (normal Z = 0; P <0.02). A
similar pattern emerged for SPA, but although the overall group
mean was reduced, there was no significant difference from
normal values (—0.53 vs. 0; P = NS). A difference did exist
between Severe OF and Mixed ROD (P < 0.03), while both
Mild OF and Severe OF were significantly reduced compared to
normal values (—1.55 and —0.75; P < 0.05). ADB had a mean
value almost equal to normal (Z =
—0.2). No significant
correlation existed between QCT or SPA scores and iPTH (Fig.
3), or any of the histomorphometric parameters.
Erosion of the terminal phalanges was seen on the plain
radiographs of 10 patients, although in one of these (patient 7)
this was thought to be due to an erosive arthropathy rather than
hyperparathyroid bone disease. If patient 7 is included, ero-
sions were seen in 7 of 15 patients with mild or severe OF on
histomorphometry, and in three patients with another diagno-
sis. Therefore, the sensitivity of plain radiography for all
degrees of OF was 50% with a specificity of 79% and a positive
predictive value of 70%. By taking into account the iPTH value,
and making the criterion for diagnosis of OF the presence of
erosions plus an iPTH greater than 65 pg/ml, sensitivity re-
mained unchanged at 50%, but specificity was greatly improved
to 93% and positive predictive value to 88%. Although radio-
graphs of the lumbar spine and pelvis allowed assessment of
bone density and texture, diagnostic information was only
obtained from the hand films.
In the two patients with osteomalacia, no specific radiological
features were seen, in particular Looser's zones were not
evident.
Discussion
Although in our experience transiliac bone biopsy is a safe
and relatively painless procedure, when performed under local
anaesthesia with intravenous midazolam sedation, it is under-
standably unpopular with patients and physicians alike. If a
non-invasive investigation, or combination of investigations,
could be found that enabled the presence, extent and type of
osteodystrophy to be diagnosed with reasonable certainty, it
would be a significant advance. Such information provides a
basis for planning vitamin D replacement therapy, choice of
phosphate binder and, in the future possibly, choice of dialysis
fluid calcium concentration.
In this study carried out on patients at the time of starting
dialysis, the most common histological diagnosis was hyper-
parathyroidism, which was judged to be mild in 7 of 30 (23%)
and severe in 8 of 30 (27%). This proportion is in agreement
with similar cross sectional studies carried out in hemodialysis
patients [6, 16]. True osteomalacia was found in only two
patients, despite the fact that 1,25-dihydroxyvitamin D3 levels
were subnormal in all patients. This confirms other reports that
osteomalacia is an uncommon diagnosis in patients not exposed
to aluminum [6, 171. The adynamic bone lesion was found in 8
of 30(27%) patients in the absence of aluminum staining, adding
Table 2. Correlation coefficients between histomorphometric
parameters and iPTH and bone alkaline phosphatase
P < 0.01, b P < 0.001; otherwise P = NS
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Table 3. Comparison of biochemical parameters in ADB, Mild OF, Severe OF and Mixed ROD
Adynamic Mild OF Severe OF Mixed ROD
Ionized Calcium 1.27 0.05 1.09 0.05 1.11 0.06 1.11 0.08
1.12—1.33 mmo!//iter
Phosphate 1.38 0.11 1.42 0.17 2.2 0.25 1.81 0.11
0.75—1.50 mmo!/iiter
1,25-Dihydroxyvitamin D3 2.4 0.8 3.6 1.0 5.3 0.7 1.7 0.9
>20 pg/mi
iPTH 21.6 1.6 152.9 1.7 495.2 1.2 132.3 1.7
10—65 pg/mi
Bone alkaline phosphatase 36.6 3.6 55.3 11.4 68.5 9.2 43.0 2.9
<110 U/liter
Total alkaline phosphatase 87.0 20.1 129.3 4.1 117.8 10.2 106.0 11.7
70—330 U/liter
Aluminum 7.8 1.9 11.4 1.5 6.6 1.8 12.0 2.4
<10 sg/liter
Fig. 1. iPTH levels plus geometric mean for the five histological
groups of renal osteodystrophy.
further weight to the argument that aluminum is unrelated to
this condition. Furthermore, it is apparent from these results
that adynamic bone is also unrelated to the process of dialysis
itself, since these patients had not undergone any renal replace-
ment therapy. In seven of the eight adynamic patients, iPTH
values were within the normal range, as has previously been
reported [18]. In contrast to other reports [19—21] the adynamic
lesion was not associated with diabetes mellitus, but this
probably reflects the small number of diabetic patients studied.
The aim of our study was to assess whether the presence and
type of renal osteodystrophy could be determined by any
combination of biochemical or radiological techniques. iPTH
clearly emerged as the most helpful investigation in this con-
text, with adynamic bone being found in 7 of 10 patients with
normal levels, and osteitis fibrosa found in 13 of 20 of those with
elevated levels. However, considerable overlap existed be-
tween the groups Mixed ROD, Mild OF and Severe OF, so that
one clearly cannot categorize all patients on this basis alone,
Histological group
iPT
>65
pg/mi
H
>200
pg/mi Erosions
iPTH +
erosions
>65
pg/mi
ADB
Sensitivity 88% 71% 57%
Specificity 91% 38% 90%
Positive predictive 78% 28% 67%
value
All OF
Sensitivity 93% 83% 50% 50%
Specificity 53% 88% 79% 93%
Positive predictive 67% 88% 70% 88%
value
Severe OF
Sensitivity 100% 80% 63% 63%
Specificity 41% 84% 75% 85%
Positive predictive 38% 67% 50% 63%
value
although an iPTH greater than 200 pg/ml suggests mild or severe
hyperparathyroid bone disease (positive predictive value 88%)
while a value below 65 pg/mI suggests adynamic bone (positive
predictive value 78%). It has been suggested that a state of mild
hyperparathyroidism is preferable to that of adynamic bone [6,
18], but no long-term studies of adynamic bone exist to support
this view. However, we would agree that if this is desirable,
then maintenance of iPTH levels at between one to two times
the upper limit of normal would be the appropriate target.
Bone alkaline phosphatase correlated with iPTH values, but
the overlap between groups was even greater and did not
increase the discrimination. Although ADB was associated with
higher levels of ionized calcium, the concentration of this ion
varies greatly from hour to hour, especially in hemodialysis
patients. Furthermore, serum calcium is greatly influenced by
oral intake and many other metabolic factors, so that single
measurements would not contribute to establishing a diagnosis.
Radiological techniques have traditionally been the mainstay
of diagnosis of renal osteodystrophy, and certainly Severe OF
was associated with the presence of erosions in the terminal
phalanges in five of eight cases. However, radiology did not
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patients had both QCT and SPA results within 2 SD of normal.
Piraino et al used QCT to measure bone mineral density in a
+ 2 SD group of 31 patients who had been on dialysis (19 peritoneal
dialysis, 10 hemodialysis) for a mean of 5.3 years [24]. It is now
known that the type of dialysis influences bone histology [25],
and therefore it may be misleading to consider peritoneal
dialysis and hemodialysis patients together. However, as in our
study, Piraino et al found that serum PTH was a better indicator
of the type of bone disease present than was QCT determined
bone density, and concluded that the usefulness of this tech-
nique in patients with renal failure is limited.
Other studies of bone mineral density in renal osteodystrophy
—2 SD have mainly used SPA of the forearm and, as in our study, have
found that mineral content tends to be lower than normal in
patients with renal failure [26—28]. While single bone density
measurements may be unhelpful, sequential studies might be
more so, having initially established the histological diagnosis
by biopsy in these patients. Decreasing bone density in a patient
known to previously have osteitis fibrosa would suggest dete-
rioration, especially if associated with a high iPTH.
In conclusion, we have found measurement of circulating
levels of iPTH to be the most helpful of the non-invasive
investigations performed in this group of patients. Plain X-ray
of the hands was the most useful radiological investigation, and
+ 2 so although single measurements of bone density did not contrib-
ute to diagnosis, sequential measurements may be useful in
follow-up. Since many end-stage renal failure patients undergo
a general anesthetic at, or around, the time of beginning
dialysis, we would advocate performing a transiliac bone biopsy
at this time to establish the definitive diagnosis, in conjunction
with a baseline iPTH level and bone density measurement.
Follow-up by non-invasive means should then enable the clini-
cian to assess the impact of further therapeutic interventions,
—2 SD and make appropriate modifications to control hyperparathy-
roidism. Whether a state of mild OF is preferable to adynamic
bone awaits the results of long-term follow-up of such patients.
1 10 100 1000
discriminate between Mild and Severe OF, and the majority of
patients were judged to have essentially normal skeletal sur-
veys. These findings are in agreement with those of Owen et al,
who compared plain skeletal radiology with bone histology in 82
patients with renal failure, and found no correlation between
radiological and histological indices [22]. We would therefore
agree with the previously quoted statements of Malluche and
Faugere [1], and question the need for the traditional annual
skeletal survey which provides a significant dose of ionizing
radiation.
Bone density measurements were, if anything, less helpful
than plain radiographs, since there was no correlation at all with
histological diagnosis. Adynamic bone was not associated with
worse bone density than any of the other groups. This is
reassuring as ADB appears to be a common diagnosis [6, 23].
Although the group as a whole had reduced bone density,
compared to age- and sex-matched normal values, some 90% of
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